Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	89.28	25.16	13.29
Graham Fair Price	41.42	25.19	17.81
PEG	-31.06	0.01	-0.02
Price/Book	-6.14	0.34	0.37
Price/Cash Flow	-53.07	26.42	56.29
Prices/Earnings	-53.07	1.51	3.21
Price/Sales	-56.39	17.40	39.89
Price/FCF	-53.07	26.42	56.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-30.02	0.70	1.00
Operating Margin	4.77	0.59	0.56
ROA	100.00	0.05	0.03
ROE	0.03	0.06	100.00
ROIC	< 0.005	0.01	125.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	0.75
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.55	1.26	128.03
EPS QOQ	1.49	1.02	-31.92
FCF QOQ	-0.17	1.00	497.18
Revenue QOQ	-0.53	1.15	119.29
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	1359.54	100.00
Days Sales Outstanding (DSO)	0.00	68.78	100.00
Inventory Turnover	0.00	0.07	100.00
Debt/Capitalization	0.02	0.02	0.73
Quick Ratio	370.72	2.94	-99.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	22.21	22.21	< 0.005
Cash	1.55	1.55	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.14	0.29	100.00
Revenue	0.20	0.44	115.24
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	370.72	3.04	-99.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.85	-3.74	-102.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating